Showing results (441-450 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|December 23, 2024
Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model MiceHiroaki Mori, Yuta Yoshino, Mariko Okano, et al.
Neuropsychopharmacology Reports|January 4, 2025
Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor SignalingHiroyuki Nawa, Masaaki Murakami
Neuropsychopharmacology Reports|December 9, 2023
Associations between relapse and drinking behaviors in patients with alcohol use disorders: A 6-month prospective studyKazuhiro Kurihara, Hotaka Shinzato, Yoshikazu Takaesu, et al.
Neuropsychopharmacology Reports|December 7, 2023
Anxious-depressive attack and rejection sensitivity-Toward a new approach to treatment-resistant depressionHisanobu Kaiya
Neuropsychopharmacology Reports|December 7, 2023
UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention-deficit/hyperactivity disorderPim Ittiphakorn, Simon Erridge, Carl Holvey, et al.
Neuropsychopharmacology Reports|December 7, 2023
An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis RegistrySimon Erridge, Ophilia Leung, Carl Holvey, et al.
Neuropsychopharmacology Reports|December 20, 2023
Machine learning algorithm-based estimation model for the severity of depression assessed using Montgomery-Asberg depression rating scaleMasanori Shimamoto, Kanako Ishizuka, Kento Ohtani, et al.
Neuropsychopharmacology Reports|February 6, 2024
Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysisTaro Kishi, Kenji Sakuma, Masakazu Hatano, et al.
Neuropsychopharmacology Reports|January 22, 2024
A multicenter, single-arm, open-label interventional study of adherence to brexpiprazole during switching from previous antipsychotic drugs in patients with schizophrenia or schizoaffective disorderKazuyuki Nakagome, Hisateru Tachimori, Shiro Endo, et al.
Neuropsychopharmacology Reports|January 24, 2024
Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot studyTomiki Sumiyoshi, Yasunori Morio, Takahiro Kawashima, et al.
Pageof 66